Cargando…

A novel approach of longitudinal adverse event evaluation in oncology clinical trials: the Toxicity over Time (ToxT) analysis of clinical trials N9741 and 979254 (Alliance)

BACKGROUND: Traditional methods of reporting adverse events (AEs) in clinical trials are inadequate for modern oncology therapies with chronic administration. Conventional analysis and display of maximum grade AEs do not capture toxicity profiles that evolve over time or longer lasting, lower grade...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thanarajasingam, Gita, Atherton, Pamela J., Novotny, Paul J., Loprinzi, Charles L., Sloan, Jeff A., Grothey, Axel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4910515/ https://www.ncbi.nlm.nih.gov/pubmed/27083333 http://dx.doi.org/10.1016/S1470-2045(16)00038-3

Ejemplares similares

The complexity of ToxT-dependent transcription in Vibrio cholerae
por: Weber, Gregor G., et al.
Publicado: (2011)

Small-Molecule Inhibitors of toxT Expression in Vibrio cholerae
por: Anthouard, Rebecca, et al.
Publicado: (2013)

The wing of the ToxR winged helix-turn-helix domain is required for DNA binding and activation of toxT and ompU
por: Morgan, Sarah J., et al.
Publicado: (2019)

Combining Survival and Toxicity Effect Sizes from Clinical Trials: NCCTG 89-20-52 (Alliance)
por: Major-Elechi, Brittny T., et al.
Publicado: (2018)

A new class of inhibitors of the AraC family virulence regulator Vibrio cholerae ToxT
por: Woodbrey, Anne K., et al.
Publicado: (2017)

1.65 Å resolution structure of the AraC-family transcriptional activator ToxT from Vibrio cholerae
por: Li, Jiaqin, et al.
Publicado: (2016)

Molecular dynamics simulation (MDS) analysis of Vibrio cholerae ToxT virulence factor complexed with docked potential inhibitors
por: Torktaz, Ibrahim, et al.
Publicado: (2018)

Prediction of bacterial small RNAs in the RsmA (CsrA) and ToxT pathways: a machine learning approach
por: Fakhry, Carl Tony, et al.
Publicado: (2017)

Expression of Cholera Toxin (CT) and the Toxin Co-Regulated Pilus (TCP) by Variants of ToxT in Vibrio cholerae Strains
por: Lee, Donghyun, et al.
Publicado: (2023)

PAM50 gene signatures and breast cancer prognosis with adjuvant anthracycline- and taxane-based chemotherapy: correlative analysis of C9741 (Alliance)
por: Liu, Minetta C, et al.
Publicado: (2016)

Inactivated Vibrio cholerae Strains That Express TcpA via the toxT-139F Allele Induce Antibody Responses against TcpA
por: Kim, Eun Jin, et al.
Publicado: (2022)

Wearable sensor-based performance status assessment in cancer: A pilot multicenter study from the Alliance for Clinical Trials in Oncology (A19_Pilot2)
por: Wood, William A., et al.
Publicado: (2023)

Promoting Accrual of Older Patients with Cancer to Clinical Trials: An Alliance for Clinical Trials in Oncology Member Survey (A171602)
por: Freedman, Rachel A., et al.
Publicado: (2018)

Testing of candidate single nucleotide variants associated with paclitaxel neuropathy in the trial NCCTG N08C1 (Alliance)
por: Boora, Ganesh K., et al.
Publicado: (2016)

Alliance for clinical trials in oncology (ALLIANCE) trial A021501: preoperative extended chemotherapy vs. chemotherapy plus hypofractionated radiation therapy for borderline resectable adenocarcinoma of the head of the pancreas
por: Katz, Matthew H. G., et al.
Publicado: (2017)

Chemotherapy in the Setting of Severe Liver Dysfunction in Patients with Metastatic Colorectal Cancer
por: Kasi, Pashtoon Murtaza, et al.
Publicado: (2015)

TOX Acts an Oncological Role in Mycosis Fungoides
por: Yu, Xin, et al.
Publicado: (2015)

Partnerships and Collaborations: The Right Alliances for Clinical Trials in Africa
por: Solarin, Olusola, et al.
Publicado: (2020)

Clinical Case—Rhus Tox
por: Potter, H. E.
Publicado: (1889)

Successes and lessons learned in database development for national multi-site cancer care delivery research trials: the Alliance for Clinical Trials in Oncology experience
por: Zahrieh, David, et al.
Publicado: (2022)

Retraction: TOX Acts an Oncological Role in Mycosis Fungoides
Publicado: (2023)

Framework of clonal mutations concurrent with WT1 mutations in adults with acute myeloid leukemia: Alliance for Clinical Trials in Oncology study
por: Bhatnagar, Bhavana, et al.
Publicado: (2023)

Sustainable development of a GCP-compliant clinical trials platform in Africa: the Malaria Clinical Trials Alliance perspective
por: Ogutu, Bernhards R, et al.
Publicado: (2010)

Draft genome sequence of Mycobacterium tuberculosis strain B9741 of Beijing B0/W lineage from HIV positive patient from Siberia
por: Shur, K.V., et al.
Publicado: (2016)

Clinical outcome assessment trends in clinical trials—Contrasting oncology and non‐oncology trials
por: Kim, Yeonju, et al.
Publicado: (2023)

Implementing the EffTox dose-finding design in the Matchpoint trial
por: Brock, Kristian, et al.
Publicado: (2017)

The comparative effectiveness of decision aids in diverse populations with early stage prostate cancer: a study protocol for a cluster-randomized controlled trial in the NCI Community Oncology Research Program (NCORP), Alliance A191402CD
por: Pacyna, Joel E., et al.
Publicado: (2018)

The Alliance AMBUSH Trial: Rationale and Design
por: Mahajan, Anita, et al.
Publicado: (2022)

Quality improvements in radiation oncology clinical trials
por: Smith, Koren, et al.
Publicado: (2023)

Racial differences in smoking abstinence rates in a multicenter, randomized, open-label trial in the United States
por: Croghan, Ivana T., et al.
Publicado: (2009)

Ethical guideposts to clinical trials in oncology
por: Bernstein, M.
Publicado: (2006)

Clinical Trials in Oncology and Defining Benefit
por: Sorscher, Steven
Publicado: (2017)

Landscape of Oncology Clinical Trials in Africa
por: Odedina, Folakemi T., et al.
Publicado: (2020)

Clinical Trial Considerations in Neuro-oncology
por: Lee, Eudocia Q.
Publicado: (2021)

The Importance of Endpoints in Oncology Clinical Trials
por: Faiman, Beth
Publicado: (2023)

Missing tumor measurement (TM) data in the search for alternative TM-based endpoints in cancer clinical trials
por: An, Ming-Wen, et al.
Publicado: (2019)

Future vision for the quality assurance of oncology clinical trials
por: FitzGerald, Thomas J., et al.
Publicado: (2013)

Integrative Medicine in Interventional Oncology: A Virtuous Alliance
por: Cornelis, François H., et al.
Publicado: (2020)

Prevalence of drug-drug interactions in oncology patients enrolled on National Clinical Trials Network oncology clinical trials
por: Marcath, Lauren A., et al.
Publicado: (2018)

Artichoke and Bergamot Phytosome Alliance: A Randomized Double Blind Clinical Trial in Mild Hypercholesterolemia
por: Riva, Antonella, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_esi4gk7akhfeqprkfdeobqtbi0